PMID- 37734180 OWN - NLM STAT- Publisher LR - 20231022 IS - 1532-8511 (Electronic) IS - 1052-3057 (Linking) VI - 32 IP - 11 DP - 2023 Nov TI - Clinical potential of automated convolutional neural network-based hematoma volumetry after aneurysmal subarachnoid hemorrhage. PG - 107357 LID - S1052-3057(23)00380-4 [pii] LID - 10.1016/j.jstrokecerebrovasdis.2023.107357 [doi] AB - OBJECTIVES: Cerebrospinal fluid hemoglobin has been positioned as a potential biomarker and drug target for aneurysmal subarachnoid hemorrhage-related secondary brain injury (SAH-SBI). The maximum amount of hemoglobin, which may be released into the cerebrospinal fluid, is defined by the initial subarachnoid hematoma volume (ISHV). In patients without external ventricular or lumbar drain, there remains an unmet clinical need to predict the risk for SAH-SBI. The aim of this study was to explore automated segmentation of ISHV as a potential surrogate for cerebrospinal fluid hemoglobin to predict SAH-SBI. METHODS: This study is based on a retrospective analysis of imaging and clinical data from 220 consecutive patients with aneurysmal subarachnoid hemorrhage collected over a five-year period. 127 annotated initial non-contrast CT scans were used to train and test a convolutional neural network to automatically segment the ISHV in the remaining cohort. Performance was reported in terms of Dice score and intraclass correlation. We characterized the associations between ISHV and baseline cohort characteristics, SAH-SBI, ventriculoperitoneal shunt dependence, functional outcome, and survival. Established clinical (World Federation of Neurosurgical Societies, Hunt & Hess) and radiological (modified Fisher, Barrow Neurological Institute) scores served as references. RESULTS: A strong volume agreement (0.73 Dice, range 0.43 - 0.93) and intraclass correlation (0.89, 95% CI, 0.81-0.94) were shown. While ISHV was not associated with the use of antithrombotics or cardiovascular risk factors, there was strong evidence for an association with a lower Glasgow Coma Scale at hospital admission. Aneurysm size and location were not associated with ISHV, but the presence of intracerebral or intraventricular hemorrhage were independently associated with higher ISHV. Despite strong evidence for a positive association between ISHV and SAH-SBI, the discriminatory ability of ISHV for SAH-SBI was insufficient. The discriminatory ability of ISHV was, however, higher regarding ventriculoperitoneal shunt dependence and functional outcome at three-months follow-up. Multivariate survival analysis provided strong evidence for an independent negative association between survival probability and both ISHV and intraventricular hemorrhage. CONCLUSIONS: The proposed algorithm demonstrates strong performance in volumetric segmentation of the ISHV on the admission CT. While the discriminatory ability of ISHV for SAH-SBI was similar to established clinical and radiological scores, it showed a high discriminatory ability for ventriculoperitoneal shunt dependence and functional outcome at three-months follow-up. CI - Copyright (c) 2023 The Author(s). Published by Elsevier Inc. All rights reserved. FAU - Thomson, Bart R AU - Thomson BR AD - Department of Neurosurgery, Clinical Neuroscience Center, Universitatsspital und University of Zurich, Ramistrasse 100, Zurich CH-8091, Switzerland; Division of Internal Medicine, Universitatsspital and University of Zurich, Zurich, Switzerland. FAU - Gurlek, Firat AU - Gurlek F AD - Department of Neurosurgery, Clinical Neuroscience Center, Universitatsspital und University of Zurich, Ramistrasse 100, Zurich CH-8091, Switzerland; Division of Internal Medicine, Universitatsspital and University of Zurich, Zurich, Switzerland. FAU - Buzzi, Raphael M AU - Buzzi RM AD - Division of Internal Medicine, Universitatsspital and University of Zurich, Zurich, Switzerland. FAU - Schwendinger, Nina AU - Schwendinger N AD - Department of Neurosurgery, Clinical Neuroscience Center, Universitatsspital und University of Zurich, Ramistrasse 100, Zurich CH-8091, Switzerland. FAU - Keller, Emanuela AU - Keller E AD - Department of Neurosurgery, Clinical Neuroscience Center, Universitatsspital und University of Zurich, Ramistrasse 100, Zurich CH-8091, Switzerland; Neurointensive Care Unit, Department of Neurosurgery, and Institute of Intensive Care Medicine, Universitatsspital and University of Zurich, Zurich, Switzerland. FAU - Regli, Luca AU - Regli L AD - Department of Neurosurgery, Clinical Neuroscience Center, Universitatsspital und University of Zurich, Ramistrasse 100, Zurich CH-8091, Switzerland. FAU - van Doormaal, Tristan Pc AU - van Doormaal TP AD - Department of Neurosurgery, Clinical Neuroscience Center, Universitatsspital und University of Zurich, Ramistrasse 100, Zurich CH-8091, Switzerland; Department of Neurology and Neurosurgery, University Medical Center Utrecht, Utrecht, The Netherlands; Department of Translational Neuroscience, University Medical Center Utrecht, Brain Center, Utrecht University, Utrecht, The Netherlands. FAU - Schaer, Dominik J AU - Schaer DJ AD - Division of Internal Medicine, Universitatsspital and University of Zurich, Zurich, Switzerland. FAU - Hugelshofer, Michael AU - Hugelshofer M AD - Department of Neurosurgery, Clinical Neuroscience Center, Universitatsspital und University of Zurich, Ramistrasse 100, Zurich CH-8091, Switzerland. FAU - Akeret, Kevin AU - Akeret K AD - Department of Neurosurgery, Clinical Neuroscience Center, Universitatsspital und University of Zurich, Ramistrasse 100, Zurich CH-8091, Switzerland. Electronic address: kevin.akeret@usz.ch. LA - eng PT - Journal Article DEP - 20230919 PL - United States TA - J Stroke Cerebrovasc Dis JT - Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association JID - 9111633 SB - IM OTO - NOTNLM OT - Angiographic vasospasm OT - Delayed cerebral ischemia OT - Delayed ischemic neurologic deficit OT - Hemoglobin OT - Imaging OT - Secondary brain injury COIS- Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Raphael M Buzzi reports financial support was provided by Swiss National Science Foundation. Dominik J Schaer reports financial support was provided by Swiss National Science Foundation. Michael Hugelshofer reports financial support was provided by Swiss National Science Foundation. Dominik Schaer reports was provided by Innosuisse Swiss Innovation Agency. Kevin Akeret reports was provided by Uniscientia Foundation. Raphael M Buzzi reports was provided by University of Zurich. Kevin Akeret reports financial support was provided by University of Zurich. Tristan PC van Doormaal reports a relationship with AugmedIT B.V. that includes: board membership. EDAT- 2023/09/22 00:42 MHDA- 2023/09/22 00:42 CRDT- 2023/09/21 18:04 PHST- 2023/06/08 00:00 [received] PHST- 2023/09/08 00:00 [revised] PHST- 2023/09/11 00:00 [accepted] PHST- 2023/09/22 00:42 [pubmed] PHST- 2023/09/22 00:42 [medline] PHST- 2023/09/21 18:04 [entrez] AID - S1052-3057(23)00380-4 [pii] AID - 10.1016/j.jstrokecerebrovasdis.2023.107357 [doi] PST - ppublish SO - J Stroke Cerebrovasc Dis. 2023 Nov;32(11):107357. doi: 10.1016/j.jstrokecerebrovasdis.2023.107357. Epub 2023 Sep 19.